Decreased mitochondrial oxidative metabolism is a hallmark bioenergetic characteristic of malignancy that may have an adaptive role in carcinogenesis. By stimulating proton leak, mitochondrial uncoupling proteins (UCP1-3) increase mitochondrial respiration and may thereby oppose cancer development. To test this idea, we generated a mouse model that expresses an epidermal-targeted keratin-5-UCP3 (K5-UCP3) transgene and exhibits significantly increased cutaneous mitochondrial respiration compared with wild type (FVB/N). Remarkably, we observed that mitochondrial uncoupling drove keratinocyte/epidermal differentiation both in vitro and in vivo. This increase in epidermal differentiation corresponded to the loss of markers of the quiescent bulge stem cell population, and an increase in epidermal turnover measured using a bromodeoxyuridine (BrdU)-based transit assay. Interestingly, these changes in K5-UCP3 skin were associated with a nearly complete resistance to chemically-mediated multistage skin carcinogenesis. These data suggest that targeting mitochondrial respiration is a promising novel avenue for cancer prevention and treatment.
INTRODUCTION
Metabolic reprogramming marked by increased glycolysis and decreased mitochondrial oxidative phosphorylation is a hallmark of malignancy. 1, 2 Whereas extensive work indicates that glycolytic upregulation promotes the growth and survival of diverse cancers, 3, 4 the evolution and functional importance of mitochondrial respiratory changes during carcinogenesis are less well understood. Increasing evidence indicates that mitochondrial respiration may suppress tumorigenesis. 5 Induction of mitochondrial inner membrane proton leak specifically increases respiration and substrate oxidation that is uncoupled from the F 1 F 0 -ATPase. Mitochondrial uncoupling proteins (UCP1-3) are the principal mediators of proton leak in diverse tissues. 6 UCP1 is expressed mainly in brown adipose tissue; however, UCP3 has a relatively broader distribution 7 and appears to be present in human basal epidermis and primary keratinocytes. 8 Here, we developed a novel mouse model with increased UCP3-dependent mitochondrial respiration in skin keratinocytes that exhibits extraordinary resistance to chemically mediated multistage skin carcinogenesis. Unexpectedly, the skin of these animals exhibited increased keratinocyte differentiation in vivo and in vitro, increased epidermal keratinocyte turnover and the loss of quiescent hair follicle bulge stem cells. Together, the results indicate that targeting mitochondrial respiratory uncoupling is a powerful novel strategy in cancer prevention and treatment, and warrants further investigation.
RESULTS AND DISCUSSION
We generated hemizygous FVB/N mice expressing a respirationinducing bovine keratin-5 promoter UCP3 (K5-UCP3) transgene in epidermal and follicular keratinocytes (Figure 1a , K5-UCP3). Isolated cutaneous mitochondria from K5-UCP3 mice exhibited increased UCP3 protein expression compared with wild type (FVB/N) skin and skeletal muscle (Figure 1b) . Histochemical analyses indicated that UCP3 was properly localized in a punctate, perinuclear mitochondrial pattern in cultured K5-UCP3 primary keratinocytes (Figure 1c) . Moreover, UCP3 expression in K5-UCP3 skin was found in the basal and suprabasal epidermal skin layers and the hair follicle (Figure 1d ).
Maximal epidermal oxygen consumption rates measured in the absence (phosphorylating state 3) or presence (non-phosphorylating state 4) of the F 1 F 0 ATPase inhibitor oligomycin were used to test for UCP3 functionality ex vivo. Both state 3 and uncoupled state 4 epidermal respiration rates were increased in K5-UCP3 compared with wild-type mice by approximately 31% and 113%, respectively (Figure 1e ). On the basis of MitoTracker Green (Grand Island, NY, USA) staining, we observed that mitochondrial mass was approximately 28% increased in K5-UCP3 keratinocytes compared with wild type (Figure 1f ). To correct for differences in mitochondrial number, we compared the percentage of uncoupled per total epidermal respiration (state 4/state 3 Â 100%) in epidermis ex vivo. K5-UCP3 epidermis exhibited an approximately two-fold increase in uncoupled per total respiration (Figure 1g ).
During the initial characterizations of the transgenic mice, we observed that isolated K5-UCP3 keratinocytes were significantly larger than wild-type cells, suggesting that enforced UCP3 expression may induce cellular differentiation. Keratinocyte differentiation is Ca 2 þ -dependent, marked by an increased cell size and fusion, and the appearance of cytoplasmic filamentous keratin strands. 9 At low [Ca 2 þ ] (p0.05 mM), cells remain small and proliferative; when cultured in 0.1 --1.2 mM Ca 2 þ , cells undergo terminal differentiation. Using light microscopy, K5-UCP3 cells grown in low (0.05 mM) Ca 2 þ exhibited clear differentiation phenotypes that were absent in wild-type keratinocytes (Figure 2a) . Similarly, transmission electron microscopy analyses showed that the large filamentous keratin strands induced by high Ca 2 þ in wild-type cells were present in K5-UCP3 cells (but not wild-type cells) cultured in low Ca 2 þ conditions ( Figure 2b ). Gene expression profiling from wild-type and K5-UCP3 skin revealed a striking increase in the expression of a large cohort of differentiation genes in K5-UCP3 skin (Figure 2c ). Among these, increased expression of keratin 10 protein in K5-UCP3 skin was confirmed by immunoblot ( Figure 2d ). Also increased in K5-UCP3 epidermis were immunoreactivities for the basal keratinocyte marker K5, along with the early and late keratinocyte differentiation markers K1, loricrin and involucrin (Figures 2d -- . Notably, the epidermis in K5-UCP3 is thicker than wild type and has an expanded layer of cells that stain positive for both K5 and K1 above the basal epidermal layer, but had decreased intensity of K5 staining. These changes appeared by 3 weeks of age (Supplementary Figure S2) . Interestingly, UCP3 messenger RNA and protein levels were significantly increased in response to calcium-induced differentiation in cultured primary mouse wild type and secondary human (HaCaT) keratinocytes, respectively (Supplementary Figures S1b --c) .
Although hotly debated, the slowly cycling (quiescent), longlived, multipotent follicular bulge stem cells are candidate progenitors of squamous carcinomas. 10, 11 These cells are marked histologically by keratin 15, and the cell surface marker CD34, and by the capacity to retain labels (for example, bromodeoxyuridine (BrdU)). 12 Interestingly, CD34 is both lost during differentiation and required for skin carcinogenesis. 13 Remarkably, hair follicle bulge regions in adult K5-UCP3 mice exhibited dramatically decreased (B85%) immunostaining for both K15 and CD34 ( Figure 3a --b) . Similarly, loss of these bulge stem cell markers was developmentally evident by 3 weeks of age (Supplementary Figures S2 --3 ). To quantify these changes, bulge stem cell populations from primary keratinocyte isolations were labeled as the CD34
þ , a-6 integrin high population 14 and analyzed by fluorescence-activated cell sorting (Figure 3c , Q2). In strong concordance with the histological data, K5-UCP3 mice exhibited an 84% decrease (0.3 vs 1.8% in wild type) in bulge stem cells ex vivo (Figure 3d ). Additionally, almost no cells in the hair follicle bulge region of K5-UCP3 skin retained BrdU after an 8-week pulsechase labeling regimen (Figure 3e ), unlike wild-type bulge regions. Surprisingly, the dramatic and overlapping lack of three distinct bulge stem cell markers in the K5-UCP3 mice did not correspond to increased bulge region apoptosis compared with wild type (Supplementary Figure S4) . Furthermore, no lack of functionality typically ascribed to bulge stem cells was observed in K5-UCP3 skin. Bulge stem cell depletion or ablation leads to hair follicle and sebaceous gland degeneration 15 and decreased wound healing.
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K5-UCP3 mice not only had normal hair follicle number and overall morphology at 3 and 7 weeks of age (Supplementary Figures S1 --2) , they also exhibited enlarged sebaceous glands and healed wounds at comparable rates with wild type (Supplementary Figure S5 ). Taken together, the increase in expression of both basal and differentiated keratinocyte markers combined with the loss of bulge stem cell markers, but not bulge stem cell functionality, suggested the possibility that epidermal turnover was accelerated in K5-UCP3 mice. To examine this possibility, we pulse-labeled basal interfollicular epidermal keratinocytes with BrdU and quantified the labeled cells that remained in the basal layer of the epidermal cells 2 h, 5 days, 7 days, 9 days, and 18 days later. Although a slightly increased percentage of K5-UCP3 basal interfollicular epidermal cells stained positive for BrdU compared with wild type at the initial 2 h time point (P ¼ 0.052), there was no difference between the genotypes 5 days after labeling (Figure 3f ). At 9 days after BrdU treatment the trend had reversed, and at 18 days after BrdU labeling, wild-type basal epidermis retained approximately 1.8% labeled cells whereas almost no label remained in the K5-UCP3 basal interfollicular epidermal cells (B0.4%, Figure 3f ). This data indicates an increased rate of epidermal turnover and loss of labeled cells in K5-UCP3 epidermis.
Given the significant effects of UCP3 expression on mitochondrial respiration, epidermal turnover, and the quiescent bulge stem cell niche, we reasoned that K5-UCP3 mice may be resistant to cancer development. Using a well-established two-stage chemically induced skin carcinogenesis model, 17 adult wild-type and K5-UCP3 mice (NX17 per genotype) were topically administered a single dose of dimethylbenzanthracene (100 mg) followed 2 weeks later with biweekly applications of 12-O-tetradecanoylphorbol-13-acetate (2.5 mg) for 26 weeks. After 15 weeks of treatment, wild-type mice developed an average of nine tumors per mouse, with 100% of the animals bearing tumors (Figures 4a  and b) . In stark contrast, none of the K5-UCP3 mice developed any tumors by 15 weeks (Figure 4a) . At 26 weeks, approximately half of the K5-UCP3 mice remained tumor-free, and those that developed tumors typically bore only one small papilloma (Figures 4b and d) . Moreover, 70% of wild-type animals developed at least one carcinoma by 26 weeks, but remarkably none of the K5-UCP3 mice developed a malignancy (Figure 4c) .
Several lines of evidence suggest that mitochondrial oxidative metabolism is tumor suppressive. Germline mutations in genes encoding mitochondrial fumarate hydratase 18 and subunits B, 19 C, 20 and D 21 of succinate dehydrogenase lead to mitochondrial dysfunction and increased susceptibility to hereditary renal cancer and paragangliomas, respectively. Similarly, the tumor suppressor p53 maintains murine mitochondrial respiratory functions, 22 and the oncogenes hypoxia-inducible factor 1-a and myc each inhibit mitochondrial oxidative metabolism. 23 Our observations strongly support a chemopreventive action of mitochondrial respiration using a novel mouse model that expresses a skin-targeted, mitochondrial respiration-inducing UCP3 transgene.
To date, only a handful of published studies in the literature deal with relationships between UCPs and cancer. Most of these are largely correlative and deal with the relatively broadly expressed close UCP3 homolog UCP2. UCP2 is associated with tumor grade in primary breast cancer and is reported to be induced in a variety of drug-resistant malignant cells and promote cell survival. 24, 25 On the other hand, in the only knockout mouse study we could find, UCP2-null mice show significantly increased incidence and severity of chemically induced colon carcinogenesis compared with wild type. 26 We demonstrated that enforced UCP2 expression is selectively toxic to malignant compared with normal cells. 27 Additionally, transgenic expression of the prototypical brown fat UCP1 in skeletal muscle decreases age-related diseases in mice, including certain types of naturally occurring hematological cancers. 28 Furthermore, the work herein is the first that we know of demonstrating chemoprotective effects of UCP3 expression in a genetically modified mouse model of carcinogenesis.
The molecular mechanisms by which UCP3 expression affects cellular differentiation and prevents skin carcinogenesis in the K5-UCP3 model remain to be defined and are under intense investigation. UCP1-3 increase mitochondrial proton leak, which in turn increases electron flux across the respiratory chain and the futile oxidation of fuels (fatty acids, carboxylic acids, NADH, FADH 2 , etc.). Uncoupling lowers the driving force for mitochondrial reactive oxidant species (ROS) generation. 29 With regard to cancer, overproduction of mitochondrial ROS from dysfunctional mitochondria is a common feature of malignancy that promotes growth and survival, and is implicated in the progression of all stages of cancer development. 30 Thus, UCP3 may antagonize carcinogenesis in part by preventing procarcinogenic ROS signaling in developing tumor cells.
Fuel substrates have also emerged as novel players linking mitochondrial dysfunction to carcinogenesis. The cytoplasmic accumulation of the mitochondrial complex II substrate succinate contributes, along with ROS, to hypoxia-inducible factor 1-a stabilization even under normoxic conditions. 31 Similarly, the suppression of mitochondrial substrate oxidation may lead to cataplerotic reactions that provide mitochondrial substrates necessary for the biosynthetic needs of rampant cell division to the cytoplasm. For example, the Kreb's cycle intermediate citrate is an essential signal for citrate-lyase-dependent cytoplasmic fatty acid biosynthesis, and is exported from mitochondria to the cytoplasm after sufficient accumulation (for example, from overfeeding or mitochondrial damage). Suppression of citrate lyase opposes cancer development, 32 and citrate lyase activity is linked to procarcinogenic histone remodeling. 33 Thus, UCP3-driven uncoupling could limit the flux of Kreb's cycle intermediates to the cytoplasm and thereby limit the biosynthetic supplies necessary for tumor development.
We also demonstrate for the first time the capacity for any uncoupling protein to promote cellular differentiation. Previous observations showing that UCP3 expression increases during skeletal myocyte differentiation 34 are consistent with our results in differentiating mouse and human keratinocytes. Ca 2 þ is the major driver of keratinocyte differentiation in mammalian skin and keratinocyte cultures. 35 Extracellular Ca 2 þ induces the release of endoplasmic reticulum Ca 2 þ , and leads to the expression of a large number of differentiation regulatory genes (transglutaminases, involucrin, etc.). Surprisingly, we could find no literature dealing with relationships between mitochondrial bioenergetics and cellular Ca 2 þ levels in keratinocytes. However, in a variety of other contexts, including neuronal and immunological synapses 36, 37 and contracting muscle fibers, 38 mitochondrial calcium sequestration is crucial for cell function. Additionally, the mitochondrial membrane potential drives mitochondrial Ca 2 þ sequestration, and mitochondrial uncoupling-induced membrane depolarization decreases sequestration. 39 Thus, mitochondrial regulation of intracellular Ca 2 þ leading to terminal differentiation of keratinocytes may be another important bioenergetic mechanism underlying UCP3-induced cancer resistance. Consistent with this idea, though Ca 2 þ per se was not examined, recent preliminary reports have implicated decreased mitochondrial membrane potential and mitochondrial dysfunction as mediators of keratinocyte differentiation. 40 The profound cancer resistance of K5-UCP3 mice corresponds with a sharp decrease in three biochemical markers of quiescent bulge stem cells, the potential progenitors of multistage squamous skin carcinomas. 41 As mentioned, loss of bulge stem cells leads not only to skin cancer resistance but also to dramatically decreased folliculogenesis, sebaceous gland development and wound healing. However, the cancer resistance observed in K5-UCP3 mice did not correspond to any apparent defect in these bulge stem cell (bSC)-mediated functions. Thus, it is likely that the bSC of K5-UCP3 mice are present, but exist in a more differentiated, less quiescent state. This idea is supported by recent observations indicating that common adult stem cell niches, including the hair follicle, contain both quiescent and active cycling populations that function cooperatively. 42 It is tempting to speculate that mitochondrial metabolism may functionally participate in the specification of stem cell fate.
Finally, we observed that UCP3 expression was lowest in undifferentiated compared with differentiated keratinocytes. Thus, expression of UCPs may be incompatible with carcinogenesis by driving the initiated stem cells to differentiate, thereby blocking promotion. Mechanistically, UCP3-induced uncoupling may lead to the accumulation of a bioenergetic messenger (for example, calcium) or metabolic process (fatty acid oxidation) that promotes differentiation while simultaneously decreasing levels of growthstimulating ROS, citrate, etc. Future work is needed to understand the complex mechanistic relationships between mitochondrial function and carcinogenesis, especially in relation to the biology of cancer stem cells. Nonetheless, this work supports a growing body of literature, indicating that important functional links exist between mitochondrial bioenergetics and carcinogenesis, and that targeting mitochondrial function is a promising avenue for cancer prevention and treatment.
